Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity

This publication has 60 references indexed in Scilit:

• Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females
  Biochemical Pharmacology, 2003
• Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-ras mutations
  Carcinogenesis: Integrative Cancer Research, 2000
• Dietary cholesterol inhibits the development of aberrant crypt foci in the colon
  Nutrition and Cancer, 1996
• SHORT COMMUNICATION: Inhibition of rat mammary tumorigenesis by dietary cholesterol
  Carcinogenesis: Integrative Cancer Research, 1996
• Importance of mevalonate‐derived products in the control of HMG‐CoA reductase activity and growth of human lung adenocarcinoma cell line a549
  International Journal of Cancer, 1993
• Regulation of the mevalonate pathway
  Nature, 1990
• p21ras is modified by a farnesyl isoprenoid.
  Proceedings of the National Academy of Sciences, 1989
• Lipid Composition and De Novo Cholesterogenesis in Normal and Neoplastic Rat Mammary Tissues
  JNCI Journal of the National Cancer Institute, 1988
• Cholestyramine promotes 7,12-dimethylbenzanthracene induced mammary cancer in Wistar rats
  British Journal of Cancer, 1987
• Essential role for mevalonate synthesis in DNA replication
  Proceedings of the National Academy of Sciences, 1979